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Background: Drug resistance to anti-malarial compounds remains a serious problem, with resistance to newer
pharmaceuticals developing at an alarming rate. The development of new anti-malarials remains a priority, and the
rational selection of putative targets is a key element of this process. Discovery-2 is an update of the original
Discovery in silico resource for the rational selection of putative drug target proteins, enabling researchers to obtain
information for a protein which may be useful for the selection of putative drug targets, and to perform advanced
filtering of proteins encoded by the malaria genome based on a series of molecular properties.
Methods: An updated in silico resource has been developed where researchers are able to mine information on
malaria proteins and predicted ligands, as well as perform comparisons to the human and mosquito host
characteristics. Protein properties used include: domains, motifs, EC numbers, GO terms, orthologs, protein-protein
interactions, protein-ligand interactions. Newly added features include drugability measures from ChEMBL,
automated literature relations and links to clinical trial information. Searching by chemical structure is also available.
Results: The updated functionality of the Discovery-2 resource is presented, together with a detailed case study of
the Plasmodium falciparum S-adenosyl-L-homocysteine hydrolase (PfSAHH) protein. A short example of a chemical
search with pyrimethamine is also illustrated.
Conclusion: The updated Discovery-2 resource allows researchers to obtain detailed properties of proteins from
the malaria genome, which may be of interest in the target selection process, and to perform advanced filtering
and selection of proteins based on a relevant range of molecular characteristics.Background
Drug resistance to current anti-parasitic compounds has
become widespread and is on the increase, including
resistance to newer treatments such as artemisinin [1,2].
While in-depth studies are ongoing on a relatively small
number of selected putative targets for future exploit-
ation, not many resources are available that focus on
performing data mining and target identification on the
complete malaria genome, in concert with relations to
chemical compounds. Currently available resources that
may be useful for target identification include PlasmoDB* Correspondence: fjoubert@postino.up.ac.za
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distribution, and reproduction in any medium[3], TDR Targets [4], PlasmoMap [5], the Tropical Diseases
Kernel [6] and also the original version of Discovery [7].
Recent approaches have illustrated the value of
predicting the association of chemical compounds with
putative protein drug targets, especially when the targets
of compounds such as the GSK dataset with known
activity against the parasite may be extrapolated using
protein-ligand interaction databases such as ChemProt
[8,9]. The Discovery resource attempts to use a similar
approach in associating chemical compounds with mal-
aria proteins using sequence homology, and also select-
ive chemical similarity searches. While the resource is
focused primarily at Plasmodium falciparum, it contains
information for all proteins from Plasmodium vivax,
Plasmodium yoelii, Plasmodium knowlesi, Plasmodium
chabaudi and Plasmodium berghei and also for the
human and mosquito hosts. Protein information includestral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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VectorBase, functional predictions, gene ontology terms,
orthology information, structural information, metabolic
pathways, predicted putative protein-ligand interactions,
druggability predictions, and literature links. The resource
also contains chemical compounds from the ChEMBL
database with chemical search functionality and putative
ligand-protein prediction information. Protein searches
may be performed using accession numbers, keywords or
an advanced multi-parameter filtering interface. Chemical
searches may be performed using keywords, SMILES
strings or chemical structures.
This new implementation of Discovery (version 2) is a
complete rewrite of the original Python-based system using
Java and NetBeans with the implementation of automated
updates based largely on web services. The previous ver-
sion included information related to sequence features,
orthology, ontology terms, structural information, meta-
bolic pathways and protein ligand interactions. The new
functionalities are the addition of expression information,
literature information from PubMed abstracts, the imple-
mentation of druggability predictions from DrugEBIlity
where available, the inclusion of malaria-related data from
the clinical trials database and the implementation of Wiki-
like user annotations. Specific advantages of Discovery-2
include extensive functionality to identify putative associa-
tions of proteins with ligands, an advanced chemical struc-
ture search interface encompassing the content of the
ChEMBL database and an interactive system for refining
putative target selections based on data mining of molecu-
lar properties. Additionally, the resource also contains data
for the mosquito and human hosts, for easy comparative
analysis.
Methods
Discovery-2 was developed in Java with NetBeans. The
protein sequences for P. berghei, P. chabaudi, P. falcip-
arum, P. knowlesi, P. vivax and P. yoelii were downloaded
from PlasmoDB (currently version 8.1). The Homo sapiens
and Anopheles gambiae proteins were downloaded from
Ensembl (currently version 64) [10] and VectorBase (cur-
rently version 3.7) [11], respectively. UniProt accessions
were assigned to the proteins using an identifier mapping
file downloaded from UniProt [12]. The UniProt accessions
were used to assign Gene Ontology (GO) annotations from
UniProt-GOA database (currently October 2012) [13].
Each GO term was linked to the Gene Ontology database
[14] and the AmiGO visualization tool [15] is used to view
the GO terms [16]. To detect orthologous genes between
the different species, ortholog clusters were generated with
OrthoMCL using mostly default parameters with a
percentage match cut-off of 50% [17]. Protein families,
domains and functional sites were identified using
InterProScan, which uses an ensemble of different methodsto automatically annotate the function and structure of
protein sequences [18]. To identify possible structures of
related proteins, a sequence similarity search against
the PDB database was carried out using NCBI BLAST,
with an E-value cut-off value of 10-6. Predicted 3D pro-
tein structures for P. falciparum and Homo sapiens
were downloaded from the MODBASE database, which
contains automatically generated homology models as
part of the MODELER project [19]. Pathway informa-
tion was obtained from KEGG PATHWAYS, MPMP
(which is the primary malaria metabolic pathways site)
[20] and Reactome [21]. Proteins were assigned path-
way information by creating links to the pathways in the
different databases they are involved in. The Enzyme
Commission numbers were assigned to the proteins using
enzyme data downloaded from the ENZYME database
hosted by ExPASy [22]. For Plasmodium species, the EC
numbers were obtained from PlasmoDB. The EC numbers
were subsequently used to link proteins to the enzyme
data in BRENDA [23] and KEGG ENZYME. Protein
sequences from the DrugEBIlity database [24], which con-
tains druggability predictions on protein structures from
PDB, were kindly provided by the ChEMBL group. A
sequence similarity search against the protein sequences
from DrugEBIlity was carried out using NCBI BLAST,
with an E-value cut-off of 10-6, in order to assess the
druggability of the matching proteins in Discovery-2 as
well as closely-related proteins. The hits were linked to
the DrugEBIlity database for more detailed information
on the druggability calculations. Data for protein-ligand
interactions was collected from the ChEMBL database.
The predictions were generated by performing a BLAST
search against the ChEMBL protein targets and finding
matching functional domains that were generated
through the InterProScan program. Expression data is
from the study performed by DeRisi et al. [25]. The litera-
ture mining was done on PubMed’s MEDLINE database
abstracts (2012) by utilizing a form of the Aho-Corasick
dictionary matching algorithm [26]. Articles are linked to
proteins if they contain malaria-related keywords, and
one of the protein’s aliases. Additionally, abstracts are
scanned for relational keywords, such as "interacts with",
to positively or negatively connect proteins with chemical
compounds from ChEMBL. Uncommon English words
that occur frequently in articles linked to proteins are
also stored. An advanced search function was designed
with the help of the Hibernate ORM (an object-relation
mapper to provide a Java object interface to the relational
database), together with a custom-built criteria library,
to ensure the fastest possible filtering of protein
sequences. Filtering can be done on various fields includ-
ing function, orthology and literature. Chemical searches
are performed using the MarvinSketch Applet, and
JChemBase (ChemAxon).
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A brief introduction to the resource
Accession and search functions
Multiple approaches can be used to access the resource in
retrieving the desired information. Data on a specific
protein of interest may be obtained through a basic or an
advanced search. In the basic search, a user may enter a
PlasmoDB/Ensembl identifier, a UniProt accession number
or alternatively perform the search using a protein name.
A built in auto-complete feature in the protein identifier
and UniProt accession searches assists users as they enter
characters in the search space. The advanced search func-
tion allows the users to filter proteins using different search
criteria in a step-by-step manner to select proteins
matching their requirements. The search criteria for filter-
ing protein sequences include organism, protein name,
function, gene ontology, the availability of structural infor-
mation, orthology, protein-ligand interactions, and the
availability of related PubMed articles. A list of proteins
matching the search criteria is returned from which the
user may select the desired protein to view detailed
information. The information for each protein is split
across tabs representing different categories of annotation
data. These tabs include “Summary”, “Function”, “Gene
Ontology”, “Orthology”, “Structure”, “Metabolic Pathways”,
“Interactions”, “Expression”, “Protein-Ligand Interactions”,
“Druggability” and “Literature”. An additional tab, “Com-
ments”, is available where users may submit comments
related to a protein in the resource.
Summary
The “Summary” tab displays the summary information for
a protein together with its amino acid sequence. The pro-
tein names and synonyms are displayed in this tab together
with the protein identifier used in the source database as
well as the UniProt accession and KEGG GENE identifier if
available.
Function
The “Function” tab displays the predicted protein fam-
ilies, domains, and functional sites predicted using
InterProScan. A graphical representation of the InterPro
features found in the protein sequence and a table de-
scribing the InterProScan analysis are shown.
Gene ontology
The “Gene ontology” tab displays the GO terms assigned
to the protein. The GO terms are categorized according
to the three domains, i.e. cellular component, molecular
function and biological processes.
Orthology
The results from the OrthoMCL clustering are displayed
in the “Orthology” tab. In this tab the multiple sequencealignment of the protein sequences that form the cluster,
generated with T-Coffee, is displayed in the JalView app-
let along with detail of the degree of conservation of the
proteins.
Structure
The “Structure” tab displays the results from a BLAST
search against the PDB database, as well as structural
predictions from MODBASE.
Metabolic pathway
The “Metabolic Pathways” tab displays MPMP, KEGG
and Reactome pathways that the protein is involved in,
as well as enzyme information if available.
Interactions
The “Interactions” tab displays the predicted protein-
protein interactions between the query protein and other
proteins. The interactions are grouped as obtained from
each of the three interaction databases (IntAct, MINT
and DIP).
Protein-ligand interactions
The “Protein-ligand interactions” tab displays the result
of BLAST searches and domain matches against the
CHEMBL targets database, and allows inspection of the
chemicals that interact with the CHEMBL blast hits.
Duggability
The “Druggability” tab displays the results of BLAST
searches against domains and proteins sequences in the
DrugEBIlity database.
Expression
The “Expression” tab displays the expression of the
selected protein over the 48 hour intraerythrocytic de-
velopmental cycle (IDC).
Literature
The “Literature” tab shows PubMed abstracts related to
the protein of interest.
Chemical searches function
Chemical searches may be performed by drawing a
structure in the MarvinSketch applet, loading an existing
structure or by providing a SMILES string. Substructure,
superstructure, exact and similarity searches are avail-
able. Results are displayed in a tabular fashion and
include the structure, ADMET properties and links to
possible interacting proteins.
Clinical trials
An additional new feature is the “Clinical Trials” page
which summarizes clinical trials related to malaria that
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an NIH-maintained resource that provides easy access to
information on publicly and privately supported clinical
studies on a wide range of diseases and conditions. This
feature in Discovery-2 allows a user to initiate searches
into Discovery using current/experimental drugs as
starting point. Compounds under investigation may be
sent to the chemical search module to find exact or
similar compounds, and possible interacting proteins
may be selected.
A sample investigation/Case study
To demonstrate the functionality available in Discovery-2,
a sample investigation was performed on the enzyme
S-adenosyl-L-homocysteine hydrolase (SAHH) from P.
falciparum. PfSAHH is involved in cysteine and methio-
nine metabolism, and has previously been proposed as a
putative drug target [27]. The enzyme is responsible for
the hydrolysis of S-adenosyl-L-homocysteine (SAH) to
adenosine and L-homocysteine that is a reversible reduc-
tion/oxidation reaction involving nicotinamide adenine
dinucleotide (NAD) as co-factor [27,28].
To search for PfSAHH in Discovery-2 using the basic
search function, the protein entry could be retrieved byFigure 1 Summary view of the protein S-adenosyl-L-homocysteine hy
information, links to other databases and protein sequence.either using the PlasmoDB identifier PFE1050w, its UniProt
accession P50250 or the enzyme name, S-adenosyl-L-
homocysteine hydrolase.
Summary
The "Summary" tab (Figure 1) provides the user with the
protein identifier from PlasmoDB, VectorBase or
Ensembl depending on the organism from which it origi-
nates. In addition known aliases for PfSAHH such as
“adenosylhomocysteinase” and “AdoHcyase” are given.
Links are provided to the PlasmoDB, Uniprot, the KEGG
database pertaining to PfSAHH. Finally, the number of
associated papers and the amino acid sequence are
given.
Function
Results from the “Function” tab (Figure 2) showed three
different InterPro identifiers that matched the query 1)
InterPro:IPR020082 matched S-adenosyl-L-homocysteine
hydrolase, conserved site, 2) InterPro:IPR015878 (S-adenosyl-
L-homocysteine hydrolase, NAD binding domain and 3)
InterPro:IPR000043 that matched Adenosylhomocysteinase.
Table 1 summarizes the InterPro entries matching the
PfSAHH protein sequence.drolase (PlasmoDB:PFE1050w), showing the basic protein
Figure 2 Functional prediction view of the protein S-adenosyl-L-homocysteine hydrolase (PlasmoDB:PFE1050w), showing a graphical
overview as well as detail of domains and motifs found by InterProScan.
Table 1 Summary of the InterPro signatures matching to
PfSAHH
InterPro entry Signatures Analysis method








IPR015878 (Domain) PF00670 (AdoHcyase_NAD) HMMPfam
IPR020082 (Site) PS00738 (ADOHCYASE_1) PatternScan
PS00739 (ADOHCYASE_2) PatternScan
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Two GO terms, GO:0004013 (adenosylhomocysteinase
activity) and GO:001-6787 (hydrolase activity) were
found to be associated with PfSAHH at the molecular
function level whereas GO:0006730 (one-carbon meta-
bolic process) is associated with the protein at a biological
process level. No GO terms were found to be associated
with PfSAHH at cellular component level.
Orthology
OrthoMCL clustering (Figure 3) showed SAHH to be
present in all eight species studied within Discovery 2.
From the Ortholog table it was noted that A. gambiae,
and H. sapiens had the same alignment length to the
Plasmodium species but differed in their sequence
length. A. gambiae, and H. sapiens showed 7 gaps with a
total gap length of 49 amino acids. From the T-coffee
alignment an insert of 42 residues were identified in all
the Plasmodium species starting at residue 145 in P.
falciparum.
Structure
A BLAST search of the PfSAHH protein sequence
against the PDB identified an exact protein sequencematch for PfSAHH (PDB:1V8B). Related protein struc-
tures that have 70% coverage with the PfSAHH sequence
are provided together with an alignment between the
target and template. In addition two MODBASE models
have been constructed for the PfSAHH protein,
PFE1050w.1 and PFE1050w.2 which were built on tem-
plates PDB:1LI4 and PDB:1V8B, respectively.
Figure 3 Orthology information for S-adenosyl-L-homocysteine hydrolase (PlasmoDB:PFE1050w), showing a T-Coffee multiple
alignment of the orthologs predicted for SPfSAHH in the other malaria species as well as the human and mosquito hosts.
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The “Metabolic Pathways” tab showed PfSAHH as
adenosylhomocysteinase with its EC number, 3.3.1.1.
The MPMP database showed the PfSAHH enzyme to be
associated with methionine and polyamine metabolism,
proteins targeted by the thioredoxin superfamily en-
zymes and S-glutathionylated proteins. The KEGG path-
way associated the enzyme with cysteine and methionine
metabolism and found it to be involved in various meta-
bolic pathways (non-specific global map of all metabolic
pathways) which include glycan biosynthesis, lipid,
carbohydrate, amino acid, nucleotide, co-factor, vitamin,
terpenoids, polyketide and energy metabolism. Reactome
showed PfSAHH to be involved in metabolism of amino
acids and derivatives as well as biological oxidations.
The metabolic pathway function provides the user with
an overview of the metabolic relevance of the target of
interest.
Protein-protein interactions
The "Interactions" tab reports protein-protein interactions
and had interaction data associated with PfSAHH within
the IntAct and MINT databases. Nine interactions were
associated with PfSAHH including itself. The UniProtaccessions for these proteins that interact with the
PfSAHH enzyme are UniProt:Q8I561 (conserved protein,
unknown function), UniProt:Q8I2F7 (ring-exported pro-
tein [REX3]), UniProt:Q8IFP1 (U5 small nuclear
ribonucleoprotein-specific protein, putative), UniProt:
O96221 (Sec31p putative), UniProt:Q8IKB6 (histone
deacetylase, putative), UniProt:Q8IIC8 (conserved pro-
tein, unknown function), UniProt:Q8IBL5 (conserved
protein, unknown function), UniProt:Q8IAZ3
(Eukaryotic translation initiation factor 3 subunit G)
and UniProt:Q8IJY1 (conserved protein, unknown func-
tion). All identified interactions were determined by the use
of a two hybrid system that uses transcriptional activity as a
measure of protein-protein interactions with all interactions
therefore being demonstrated by physical associations.
Protein-ligand interactions
Protein-ligand interactions were identified by a BLAST
search against the CHEMBL targets database, and were
reported in the targets section with the ligands associ-
ated in the ligand section (Figure 4). PfSAHH was iden-
tified from the CHEMBL targets database along with
SAHH from other organisms including Mus musculus,
Homo sapiens and Thermotoga maritima, all showing
Figure 4 Protein-ligand interaction view for S-adenosyl-L-homocysteine hydrolase (PlasmoDB:PFE1050w), showing predicted
interactions with a series of ligands, based on a BLAST hit to ChEMBL. An alignment to the BLAST hit is also shown.
Mpangase et al. Malaria Journal 2013, 12:116 Page 7 of 9
http://www.malariajournal.com/content/12/1/116good BLAST hits. Domain matching of PfSAHH showed
no additional matches compared to the BLAST results
for the complete protein sequence. Two hundred and
ninety-one chemical compounds were identified which
have been tested for activity against PfSAHH and its
homologs, 819 respective bioactivities involving those
compounds were found.
Druggability
Druggability data for PfSAHH, showed that the molecules
with the most significant BLAST domain matches from
DrugEBIlity (PfSAHH crystal structure and PDB:1V8B)
are not predicted to be druggable, although tractability is
indicated. From the BLAST alignments PfSAHH (UniProt:
P50250) had 0% overall druggability whilst the top two ho-
mologues UniProt:P60176 (SAHH from Mycobacterium tu-
berculosis) and UniProt:Q3JY79 (SAHH from Burkholderia
pseudomallei, strain 1710b) had druggability scores of 48%
and 45%, respectively.
Expression
The results in the expression view indicate that the pro-
tein is expressed predominantly in the trophozoite stage
and is under-expressed in the early ring stage, indicatingthat it may have a role in parasite growth and prepar-
ation for division.
Literature
The literature functionality showed 26 articles related to
SAHH from PubMed abstracts. The compounds cyst-
eine, adenosine, aristeromycin, and ilimaquinone are
shown as the main possible interactors with SAHH
based on text relation mining of abstracts.
In summary, it was possible to demonstrate by means of
a single search that the protein PfSAHH has ahcY,
AdiHcyase and Ad_hcy_hydrolase signatures and that
orthologs are found in the other Plasmodium species as well
as the human and mosquito hosts. The Plasmodium en-
zymes have insertions in relation to the hosts’ enzymes, and
a crystal structure as well as homology models are available
for the P. falciparum enzyme. Experimental protein-protein
interaction evidence is available, and despite a relatively
weak druggability score, a wide range of compounds that
potentially interact with the enzyme are highlighted.
A sample investigation using a chemical structure
As a brief example of a compound-based search using a
known anti-malarial drug, the SMILES string for
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was performed. The compound 5-(4-chlorophenyl)-6-
ethylpyrimidine-2,4-diamine (pyrimethamine) was re-
trieved as the only hit. The compound information view
provided detail about the molecular mass, hydrogen bond
donor count, acceptor count, logP, logD, ring count and
rotatable bond count, which are all relevant properties for
the selection of druggable compounds. The compound
passed the Lipinski rule of five [29]. When a search for pu-
tative targets was performed, a series of dihydrofolate re-
ductase and bifunctional dihydrofolate reductase –
thymidylate synthase enzymes were found in all the rele-
vant species. This included the Plasmodium falciparum
drug target, PFD0830w.Conclusions
Discovery-2 is an update of the original Discovery
resource, and is a complete rewrite of the system utiliz-
ing an updated database structure and new software
technologies, and underlying functionality to perform
automated updates using web services. A series of new
features have been added such as relations to targets and
compounds in ChEMBL, links to druggability informa-
tion, automated literature links and relations to com-
pounds in clinical trials.
The resource allows researchers to perform quick
searches based on specific proteins, but to also perform
mining and filtering of possible drug targets based on a
series of molecular properties. Results provide the re-
searcher with information about the protein’s functional
annotations, ontology terms, orthology to the different
malaria parasite species and host proteins, structural in-
formation, pathway information, protein and ligand
interaction information, druggability information and
literature links. These result categories were selected to
optimally assist researchers in selecting proteins for
further detailed in silico and experimental investigation
to assess the suitability of the protein as a putative drug
target.
It is hoped that this resource enables the malaria com-
munity to quickly and easily obtain information related to
the suitability of a protein as a drug target, and to perform
the in silico selection of proteins from the malaria genome
to effectively reduce the data space for further detailed
experimentation.Availability
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